11
TITLE: Anticancer activity and paraptosis induction of novel bipyridine-silver(I) compounds against resistant colorectal and ovarian cancer cell lines
AUTHORS: Stefanelli, A; Teixeira, RG; Pilon, A; Warmers, R; Ott, I; Kowol, CR; Brozovic, A; Tomaz, AI; Valente, A; Heffeter, P;
PUBLISHED: 2023, SOURCE: CANCER RESEARCH, VOLUME: 83, ISSUE: 7
INDEXED IN: WOS CrossRef
IN MY: ORCID
12
TITLE: Cyclodextrins Initiated Ring-Opening Polymerization of Lactide Using 4-Dimethylaminopyridine (DMAP) as Catalyst: Study of DMAP/beta-CD Inclusion Complex and Access to New Structures  Full Text
AUTHORS: Meimoun, J; Phuphuak, Y; Miyamachi, R; Miao, Y; Bria, M; Rousseau, C; Nogueira, G; Valente, A; Favrelle Huret, A; Zinck, P;
PUBLISHED: 2022, SOURCE: MOLECULES, VOLUME: 27, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
13
TITLE: Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs  Full Text
AUTHORS: Teixeira Guedes, Catarina; Bras, Ana Rita; Teixeira, Ricardo G.; Valente, Andreia; Preto, Ana;
PUBLISHED: 2022, SOURCE: PHARMACEUTICS, VOLUME: 14, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 12
IN MY: ORCID
14
TITLE: Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model  Full Text
AUTHORS: Corte Real, Leonor; Bras, Ana Rita; Pilon, Adhan; Mendes, Nuno; Ribeiro, Ana Sofia; Martins, Tiago D.; Farinha, Jose Paulo S.; Conceicao Oliveira, M.; Gartner, Fatima; Helena Garcia, M.; Preto, Ana; Valente, Andreia;
PUBLISHED: 2022, SOURCE: PHARMACEUTICS, VOLUME: 14, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
15
TITLE: Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds
AUTHORS: Teixeira, RG; Belisario, DC; Fontrodona, X; Romero, I; Tomaz, AI; Garcia, MH; Riganti, C; Valente, A;
PUBLISHED: 2021, SOURCE: INORGANIC CHEMISTRY FRONTIERS, VOLUME: 8, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 21
IN MY: ORCID
16
TITLE: Heteroleptic enantiopure Pd(ii)-complexes derived from halogen-substituted Schiff bases and 2-picolylamine: synthesis, experimental and computational characterization and investigation of the influence of chirality and halogen atoms on the anticancer activity  Full Text
AUTHORS: Kordestani, N; Rudbari, HA; Correia, I; Valente, A; Corte Real, L; Islam, MK; Micale, N; Braun, JD; Herbert, DE; Tumanov, N; Wouters, J; Enamullah, M;
PUBLISHED: 2021, SOURCE: NEW JOURNAL OF CHEMISTRY, VOLUME: 45, ISSUE: 20
INDEXED IN: Scopus WOS CrossRef: 12
IN MY: ORCID
18
TITLE: Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance  Full Text
AUTHORS: Valente, A; Podolski Renic, A; Poetsch, I; Filipovic, N; Lopez, O; Turel, I; Heffeter, P;
PUBLISHED: 2021, SOURCE: DRUG RESISTANCE UPDATES, VOLUME: 58
INDEXED IN: Scopus WOS CrossRef: 57
IN MY: ORCID
19
TITLE: Anticancer Activity and In Vitro to In Vivo Mechanistic Recapitulation of Novel Ruthenium-Based Metallodrugs in the Zebrafish Model
AUTHORS: Karas, BF; Hotz, JM; Gural, BM; Terez, KR; DiBona, VL; Corte Real, L; Valente, A; Buckley, BT; Cooper, KR;
PUBLISHED: 2021, SOURCE: TOXICOLOGICAL SCIENCES, VOLUME: 182, ISSUE: 1
INDEXED IN: WOS CrossRef: 10
IN MY: ORCID
20
TITLE: Ruthenium and iron metallodrugs: New inorganic and organometallic complexes as prospective anticancer agents
AUTHORS: Valente, A; Morais, TS; Teixeira, RG; Matos, CP; Tomaz, AI; Helena Garcia, M;
PUBLISHED: 2021, SOURCE: Synthetic Inorganic Chemistry: New Perspectives
INDEXED IN: Scopus CrossRef: 5
IN MY: ORCID
Page 2 of 7. Total results: 64.